Diligence memo · auto-generated · as of July 3, 2026

Riverview Surgical Center, Llc

Riverview Surgical Center, Llc looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Riverview Surgical Center, Llc operates in Hospitals and Physicians, based in SIOUX CITY.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Riverview Surgical Center, Llc has raised $640K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $640K on 2017-04-26.

Most recent recorded round closed around 2017-04-26.

Valuation (modeled)modeled

Provath models Riverview Surgical Center, Llc at approximately $18M (range $418K–$208M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.13× the median modeled value of Pre-Seed Hospitals and Physicians companies in 2016–2018 (39 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 9.2 yr ago; this sector typically re-raises about every 12 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 26% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 45% of those peers.

Closest niche peers: Oriental Dolphins CCG II Lender LLP, Grand View Surgery Center at Harleysville, LLC, St. Luke's Surgery Center of Chesterfield, LLC, Summit Medical Group, LLC, Methodist McKinney Hospital, LLC.

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.